"Relapse free survival" trang 1 - tải miễn phí từ tailieunhanh
Monthly tegafur–uracil maintenance for increasing relapse-free survival in ypStage III rectal cancer patients after preoperative radiotherapy, radical resection, and 12 postoperative chemotherapy cycles: A retrospective study

Monthly tegafur–uracil maintenance for increasing relapse-free survival in ypStage III rectal cancer patients after preoperative radiotherapy, radical resection, and 12 postoperative chemotherapy cycles: A retrospective study
11    63    0
Prognostic factors for relapse-free survival in stage IB-IIIA primary lung adenocarcinoma by epidermal growth factor receptor mutation status

Prognostic factors for relapse-free survival in stage IB-IIIA primary lung adenocarcinoma by epidermal growth factor receptor mutation status
11    1    1
Single nucleotide polymorphism rs13042395 in the SLC52A3 gene as a biomarker for regional lymph node metastasis and relapse-free survival of esophageal squamous cell carcinoma patients

Single nucleotide polymorphism rs13042395 in the SLC52A3 gene as a biomarker for regional lymph node metastasis and relapse-free survival of esophageal squamous cell carcinoma patients
11    53    1
The clinicopathological characteristics of POLE-mutated/ultramutated endometrial carcinoma and prognostic value of POLE status: A meta-analysis based on 49 articles incorporating 12,120 patients

The clinicopathological characteristics of POLE-mutated/ultramutated endometrial carcinoma and prognostic value of POLE status: A meta-analysis based on 49 articles incorporating 12,120 patients
15    8    1
Impact of the epidermal growth factor receptor mutation status on the prognosis of recurrent adenocarcinoma of the lung after curative surgery

Impact of the epidermal growth factor receptor mutation status on the prognosis of recurrent adenocarcinoma of the lung after curative surgery
8    41    1
Foxp3 overexpression in tumor cells predicts poor survival in oral squamous cell carcinoma

Foxp3 overexpression in tumor cells predicts poor survival in oral squamous cell carcinoma
7    53    1
Higher number of multidisciplinary tumor board meetings per case leads to improved clinical outcome

Higher number of multidisciplinary tumor board meetings per case leads to improved clinical outcome
9    107    0
Neutrophil-to-lymphocyte ratio is a prognostic factor for colon cancer: A propensity score analysis

Neutrophil-to-lymphocyte ratio is a prognostic factor for colon cancer: A propensity score analysis
8    49    1
Nomogram predict relapse-free survival of patients with thymic epithelial tumors after surgery

Nomogram predict relapse-free survival of patients with thymic epithelial tumors after surgery
11    19    1
Dentate line invasion as a predictive factor of poor distant relapse-free survival in locally advanced lower rectal cancer with anal sphincter involvement

Dentate line invasion as a predictive factor of poor distant relapse-free survival in locally advanced lower rectal cancer with anal sphincter involvement
12    1    1
Influence of pre-operative oral carbohydrate loading vs. standard fasting on tumor proliferation and clinical outcome in breast cancer patients ─ a randomized trial

Influence of pre-operative oral carbohydrate loading vs. standard fasting on tumor proliferation and clinical outcome in breast cancer patients ─ a randomized trial
22    69    0
Trastuzumab without chemotherapy in the adjuvant treatment of breast cancer: Subgroup results from a large observational study

Trastuzumab without chemotherapy in the adjuvant treatment of breast cancer: Subgroup results from a large observational study
7    39    1
An increase in the neutrophil-to-lymphocyte ratio during adjuvant chemotherapy indicates a poor prognosis in patients with stage II or III gastric cancer

An increase in the neutrophil-to-lymphocyte ratio during adjuvant chemotherapy indicates a poor prognosis in patients with stage II or III gastric cancer
8    80    1
Size and number of lymph nodes were risk factors of recurrence in stage II colorectal cancer

Size and number of lymph nodes were risk factors of recurrence in stage II colorectal cancer
10    9    1
Influence on therapeutic outcome of platelet count at diagnosis in patients with de novo non-APL acute myeloid leukemia

Influence on therapeutic outcome of platelet count at diagnosis in patients with de novo non-APL acute myeloid leukemia
9    6    1
LGR5 overexpression confers poor relapse-free survival in breast cancer patients

LGR5 overexpression confers poor relapse-free survival in breast cancer patients
8    37    1
The impact of clinicopathologic and surgical factors on relapse and pregnancy in young patients (≤40 years old) with borderline ovarian tumors

The impact of clinicopathologic and surgical factors on relapse and pregnancy in young patients (≤40 years old) with borderline ovarian tumors
11    60    1
Prognostic impact of AJCC response criteria for neoadjuvant chemotherapy in stage II/III breast cancer patients: Breast cancer subtype analyses

Prognostic impact of AJCC response criteria for neoadjuvant chemotherapy in stage II/III breast cancer patients: Breast cancer subtype analyses
10    80    1
Breast cancers with high DSS1 expression that potentially maintains BRCA2 stability have poor prognosis in the relapse-free survival

Breast cancers with high DSS1 expression that potentially maintains BRCA2 stability have poor prognosis in the relapse-free survival
12    71    1
Clinical impact of primary tumor sidedness and sex on unresectable post-recurrence survival in resected pathological stage II-III colorectal cancers: A nationwide multicenter retrospective study

Clinical impact of primary tumor sidedness and sex on unresectable post-recurrence survival in resected pathological stage II-III colorectal cancers: A nationwide multicenter retrospective study
10    26    1